Petco at Goldman Sachs Conference: Strategic Transformation Focus

Petco Health and Wellness Company Inc. (NASDAQ:WOOF) outlined its strategic transformation at the Goldman Sachs Global Retailing Conference, detailing progress in Phase Two focused on execution and profitability, with Phase Three growth initiatives slated for 2026. The company is improving retail fundamentals, driving EBITDA and gross margin expansion through disciplined operations, including approximately 25 store closures this year and optimizing its 300 veterinary service locations. Key future growth drivers include scaling services, merchandise differentiation, and omnichannel enhancements, while management maintains cautious optimism regarding consumer resilience and continues to focus on efficient inventory management, with levels down 9.5% against sales down 2%.

Analysis

Petco's management has articulated a clear, phased turnaround strategy focused on restoring operational and financial discipline before embarking on future growth. The company is currently in Phase Two, concentrating on execution and profitability, which has already yielded tangible improvements in EBITDA through the first half of the year. Key initiatives driving this include aggressive inventory management, resulting in a 9.5% reduction against a 2% sales decline, and a more disciplined promotional strategy that eliminates margin-eroding discount stacking. Further, a newly established professional procurement team is leveraging the company's scale to renegotiate supplier and freight contracts, providing a structural tailwind for margins. The store footprint is being actively managed, with approximately 25 closures planned for this year, but significant flexibility is afforded by over half of the company's leases coming up for renewal in the coming years. Looking ahead to Phase Three, which begins in 2026, growth will be pursued via a de-risked 'test and learn' approach centered on four pillars: store experience, merchandise differentiation, omnichannel integration, and scaling its services division. Management views its 300-location veterinary network as a key competitive moat, driving traffic and differentiation, and plans to optimize this existing fleet without significant new capital expenditure. While management is cautiously optimistic about consumer resilience, they are monitoring the potential impact of rising consumer debt on 2026 performance.

Key Decisions for Investors

• Investors should monitor near-term execution on stated profitability goals, specifically tracking gross margin expansion and EBITDA performance in coming quarters to validate the effectiveness of Phase Two's operational turnaround.
• The negative spread between inventory and sales is a critical indicator of discipline; continued management of inventory below sales levels should be viewed as a key positive for cash flow and margin protection in a volatile macro environment.
• The capital-light nature of the forward strategy, which prioritizes optimizing the existing 300 vet centers and a cautious 'test and learn' approach to merchandising, suggests a de-risked path to growth that should be factored into valuation models for 2026 and beyond.
• Pay close attention to management's commentary on consumer health, as the acknowledged risk of rising consumer debt could pressure the discretionary side of the business and temper the growth trajectory forecasted for 2026.